retatrutide clinical trial dosing retatrutide Guide: 1-12 mg Weekly Triple Agonist (2026) Retatrutide microdosing: guide to split

Mechanism differences that matter Beyond the weight loss numbers, the glucagon receptor component gives retatrutide properties that semaglutide and tirzepatide lack

Collins L et al

Last reviewed: June 11, 2026 Last updated: June 11, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

A recent study from the Cleveland Clinic showed that genetic variants also play a significant role in the response to GLP-1 RAs, like semaglutide, for weight loss

GLP-1 medications are FDA-approved for type 2 diabetes management and, at higher doses, for chronic weight management in adults with obesity or overweight with weight-related comorbidities

Many patients find the act of manual entry increases awareness and engagement